(Q51071320)

28 March 2018

title

HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. (English)

1 reference

28 March 2018

1 reference

1 reference

1 reference

1 reference

2

1 reference

28 March 2018

Robert Vierkant

series ordinal

3

1 reference

28 March 2018

Gregory A. Poland

series ordinal

5

object named as

Gregory A Poland

1 reference

28 March 2018

1

Inna G Ovsyannikova

1 reference

28 March 2018

author name string

V Shane Pankratz

series ordinal

4

1 reference

28 March 2018

language of work or name

English

0 references

publication date

19 January 2007

1 reference

28 March 2018

published in

Vaccine

1 reference

28 March 2018

volume

25

1 reference

28 March 2018

issue

16

1 reference

28 March 2018

page(s)

3090-3100

1 reference

28 March 2018

The genetic basis for variation in antibody response to vaccines.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

A new categorization of HLA DR alleles on a functional basis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

The contribution of HLA class I antigens in immune status following two doses of rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Human Leukocyte Antigen Class II Alleles and Rubella‐Specific Humoral and Cell‐Mediated Immunity following Measles‐Mumps‐Rubella–II Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Therapeutics and toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Advantage of rare HLA supertype in HIV disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Nomenclature for factors of the HLA system, 1995

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

MHC ligands and peptide motifs: first listing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.020

10.1016/J.VACCINE.2007.01.020

7 January 2021

Identifiers

DOI

1 reference

28 March 2018

PubMed ID

17280755

1 reference

28 March 2018